• Almac Invests $830M to Expand Crystallization Capabilities contractpharma
    July 02, 2021
    Almac Sciences has invested approximately $485 million in an automated crystallization platform to support solid form screening of polymorphs, salts and crystals in addition to crystallization of amorphous materials.
PharmaSources Customer Service